Valeant Makes Good On Threat Of Hostile $53B Allergan Play
Valeant Pharmaceuticals International Inc. took its $53 billion takeover proposal straight to Allergan Inc. shareholders on Wednesday, one day after the company confirmed it would launch an exchange offer alongside activist...To view the full article, register now.
Already a subscriber? Click here to view full article